Category: Dispensaries
-
Vext Science (VEXT.C) cannabis chart defies gravity
“The core business, which is derived from an Arizona licensed vertically integrated model, generated USD $13 million in revenues during the first two quarters of 2019,” confirmed Equity Guru’s Sam Bourgi last October. Ironically, VEXT is a healthy cannabis business, and investors are quickly gaining confidence in it.
-
This is an actual MedMen (MMEN.C) news release
When a cannabis company loses a lot of money every quarter, and has to sell real estate, cancel acquisitions, lay off staff, renegotiate existing financing to higher interest rates and offer stock to new financiers at a discount to the market price, all to stay afloat, one might expect their newsflow to show bold new…
-
![SLANG Worldwide (SLNG.C) enters a new US market]()
SLANG Worldwide (SLNG.C) enters a new US market
This deal gives Standard Wellness an exclusive license to produce and distribute the SLANG product suite in Ohio. SLANG will derive revenue for each branded product sold in the state, with sales expected to begin in 2020.
-
2019 weed wrap: The end of the cannabis cycle of cannabis cycles
Like the old Twilight Zone episode where helpful aliens leave behind a book called ‘To Serve Man’, only for us to find out later it’s a cookbook, investors have been welcomed and fattened up nicely by alpha predators as they unwittingly await their slaughter, not realizing that, they’re at the predator’s table because they’re the…
-
Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it
If you’ve been around this joint for a while, you’ll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging on to your money is a thing you aspire to do. That’s not because we have a hate on for the dude-bros running the show, or because they’re not a…
-
![CLS Holdings (CLSH.C) completes phase 1 of Las Vegas cannabis facility]()
CLS Holdings (CLSH.C) completes phase 1 of Las Vegas cannabis facility
On December 5, 2019 CLS Holdings (CLSH.C) announced that it has completed the buildout and licensing for phase 1 of its north Las Vegas processing facility. The CLS business model includes licensing, extraction, processing, sale of products, brand creation and consulting services. CLSH has developed a proprietary method of extracting cannabinoids from cannabis plants and…
-
![Chemesis (CSI.C) Q1, 2020 cannabis revenue up 279% – official “survivor” status?]()
Chemesis (CSI.C) Q1, 2020 cannabis revenue up 279% – official “survivor” status?
On January 10, 2018 (almost two years ago), the Canadian Marijuana Index peaked just north of a 1,000. At that time, the valuation of almost every cannabis company looked rich. Today, the Canadian Marijuana Index is at 212 (down 80%). These days, the pom-poms are locked firmly in a drawer, but it is worth pointing…
-
![SOL Global (SOL.C) revs up in Florida, financials dragged down by Verano investment]()
SOL Global (SOL.C) revs up in Florida, financials dragged down by Verano investment
On December 2, 2019 Sol Global (SOL.C) released its Q2, financial results for the three and six-month period ended September 30, 2019. SOL Global invests in cannabis related companies in legal U.S. states, hemp and CBD marketplaces and the emerging European cannabis and hemp territories. Its business activities encompass cultivation, distribution, retail – and an…
-
![MedMen (MMEN.C): cannabis catastrophe – 5 red flags everyone should have seen]()
MedMen (MMEN.C): cannabis catastrophe – 5 red flags everyone should have seen
MedMen (MMEN.C) owns 33 cannabis retail stores across 9 states. The stores have attractive exteriors, but the business inside is ugly. “MedMen reported another quarter of heavy losses [In Q1, 2020] as the California-based cannabis company scrambles to right-size and avoid bankruptcy,” reported an excellent Grizzle article, “with $11 million of quarterly interest expense against…
-
Yeah we lost money, what’s it to you? 1933 Industries (TGIF.C) takes the transparent route and we love it
Regular readers will know I’ve been a little quiet of late on the cannabis space, which is by design. If I’m not going in full welly on a given sector or company, I’m certainly not going to suggest you should, and quite frankly the cannabis business was overdue for a reckoning, as I stated back…
